(Q46941948)

26 December 2017

title

Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis (English)

1 reference

26 December 2017

cost-effectiveness analysis

main subject

1 reference

1 reference

Xavier Bresse

1

1 reference

26 December 2017

Lieven Annemans

2

1 reference

26 December 2017

Emmanuelle Préaud

3

1 reference

26 December 2017

Karine Bloch

4

1 reference

26 December 2017

Gérard Duru

5

1 reference

26 December 2017

Aline Gauthier

6

1 reference

26 December 2017

publication date

28 March 2013

1 reference

26 December 2017

Expert Review of Pharmacoeconomics & Outcomes Research

published in

1 reference

26 December 2017

volume

13

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

393-406

1 reference

26 December 2017

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

cites work

1 reference

Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey

21 January 2018

1 reference

Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice.

21 January 2018

1 reference

Herpes zoster (shingles) and postherpetic neuralgia

21 January 2018

1 reference

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

21 January 2018

1 reference

Varicella vaccination in Europe: are we ready for a universal childhood programme?

21 January 2018

1 reference

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

21 January 2018

1 reference

Seroprevalence of varicella in the French population

21 January 2018

1 reference

Prevention of herpes zoster and its painful and debilitating complications

21 January 2018

1 reference

Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up

21 January 2018

1 reference

The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial

21 January 2018

1 reference

The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine

21 January 2018

1 reference

Assessment of pain in herpes zoster: lessons learned from antiviral trials

21 January 2018

1 reference

[Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].

21 January 2018

1 reference

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

21 January 2018

1 reference

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

Natural history of pain following herpes zoster

21 January 2018

1 reference

The burden of Herpes Zoster: a prospective population based study

21 January 2018

1 reference

Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publications

21 January 2018

1 reference

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years

21 January 2018

1 reference

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy

21 January 2018

1 reference

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

21 January 2018

1 reference

Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium.

21 January 2018

1 reference

Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland

21 January 2018

1 reference

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

21 January 2018

1 reference

Herpes zoster: Burden of disease in France.

21 January 2018

1 reference

Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors

21 January 2018

1 reference

The burden of neuropathic pain: results from a cross-sectional survey.

21 January 2018

1 reference

Vaccination against Herpes Zoster and Postherpetic Neuralgia

21 January 2018

1 reference

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

21 January 2018

1 reference

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

21 January 2018

1 reference

A systematic review of the cost effectiveness of herpes zoster vaccination

21 January 2018

1 reference

Principles of good modeling practice in healthcare cost-effectiveness studies

21 January 2018

1 reference

Cost effectiveness of herpes zoster vaccine in Canada.

21 January 2018

1 reference

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

Herpes zoster and quality of life: a self-limited disease with severe impact.

21 January 2018

1 reference

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

21 January 2018

1 reference

Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.13.19

1 reference

26 December 2017

1 reference

26 December 2017